Menu Search
Equities

AK Medical Holdings Ltd

1789:HKG.HS

AK Medical Holdings Ltd

Actions
  • Price (HKD)4.42
  • Today's Change0.01 / 0.23%
  • Shares traded592.00k
  • 1 Year change-43.41%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AK MEDICAL HOLDINGS Ltd is an investment holding company principally engaged in design, develop, produce and market orthopedic implants and related products. The Company, along with its subsidiaries, operates its businesses through two segments, including China Orthopedic Implants segment and United Kingdom Orthopedic Implants segment. The Company's businesses mainly include hip and knee implants business, spine and trauma implants business, customized products and services, research and development business. The Company also engages in joints business, spine business, overseas business and digital orthopedics business. The Company mainly conducts its businesses in the domestic market and overseas markets.

  • Revenue in HKD (TTM)1.18bn
  • Net income in HKD196.59m
  • Incorporated2015
  • Employees1.05k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.